Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines-Reference-Cited by-同舟云学术

Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines

Published:2020 Issue:4 Volume:49 Page:1207-1219
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Fandzloch Marzena¹²³⁴⁵^ORCID,Jaromin Anna⁶⁷²⁸⁴^ORCID,Zaremba-Czogalla Magdalena⁶⁷²⁸⁴^ORCID,Wojtczak Andrzej¹⁹¹⁰⁴^ORCID,Lewińska Agnieszka¹²³⁴,Sitkowski Jerzy¹¹¹²⁴¹³¹⁴,Wiśniewska Joanna¹⁹¹⁰⁴^ORCID,Łakomska Iwona¹⁹¹⁰⁴^ORCID,Gubernator Jerzy⁶⁷²⁸⁴

Affiliation:

1. Faculty of Chemistry

2. University of Wroclaw

3. 50-383 Wrocław

4. Poland

5. Institute of Low Temperature and Structure Research

6. Department of Lipids and Liposomes

7. Faculty of Biotechnology

8. 50-383 Wroclaw

9. Nicolaus Copernicus University in Toruń

10. 87-100 Toruń

11. National Institutes of Medicines

12. 00-725 Warszawa

13. Institute of Organic Chemistry

14. Polish Academy of Sciences

Abstract

One of the six new Ru(ii) complexes synthesized using purine analogues, such as triazolopyrimidines, encapsulated in PEG-modified liposomes, representing an effective alternative for enhanced selective cytotoxicity against melanoma cell lines.

Funder

Narodowe Centrum Nauki

Ministerstwo Nauki i Szkolnictwa Wyższego

Krajowy Naukowy Osrodek Wiodacy

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/DT/C9DT03464A

Reference59 articles.

1. The global burden of melanoma: results from the Global Burden of Disease Study 2015